The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...

SAVANNAH — Hyundai has begun producing electric SUVs in Georgia less than two years after breaking ground on its $7.6 billion ...

The U.S. Supreme Court on Monday rejected appeals from two high-profile figures: R&B singer R. Kelly, and former ...

The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

The judge cited Shkreli’s “particularly heartless and coercive” tactics in monopolizing Daraprim and keeping generic rivals ...

The Supreme Court has rejected an appeal from Martin Shkreli, popularly known as “Pharma Bro,” upholding a $64.6 million ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

The Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the ...

As on 30-06-2024, the company has a total of 239.93 Crore shares outstanding.As of 7th Oct,2024, the Sun Pharma Share Price on NSE closed at Rs. 1902.45, featuring amongst the most traded securities ...

Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition, Bristol-Myers Squibb will ...